Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.
Over the past year, many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders sold a significant stake in the company...
Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys are included in this Analyst Blog.